Comparison Of Post Operative Pain Relief In Patients Undergoing Laparoscopic General Surgery, with Bupivacaine as against methylene Blue with Bupivacaine.
Phase 4
- Registration Number
- CTRI/2022/12/048237
- Lead Sponsor
- SIR H.N RELIANCE FOUNDATION HOSPITA
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
PATIENTS GIVING INFORMED VALID CONSENTS
PATIENTS UNDERGOING LAPAROSCOPIC SURGERY UNDER GENERAL ANAESTHESIA
Exclusion Criteria
1)PATIENTS UNWILLING TO GIVEN CONSENT
2) AGE LESS THAN 18 YEARS OR MORE THAN 70 YEARS
3) DOCUMENTED ALLERGY OR INTOLERANCE TO STUDY COMPOUND
4) ANY SEVERE PERI-OPERATIVE COMPLICATIONS
5) PATIENTS ON CHRONIC PAIN MEDICATIONS
6) INTRA-OPERATIVE CONVERSION FROM LAPAROSCOPIC TO OPEN
7) PREGNANCY OR LACTATING MOTHERS
8) CO-EXISTNG SEVERE CARDIOVASCULAR, NEUROLOGICAL, HEPATIC, RENAL OR ENDOCRINOLOGICAL DISTURBANCES.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method To assess efficiency of Methylene blue as an adjuvant to LA in TAP block by assessing the VAS scale at different time intervals of 4,8,12, and 24 hours, post operatively.Timepoint: To assess efficiency of Methylene blue as an adjuvant to LA in TAP block by assessing the VAS scale at different time intervals of 4,8,12, and 24 hours, post operatively.
- Secondary Outcome Measures
Name Time Method To evaluate the total analgesic requirement in the first 24 hours post-surgery of laparoscopic surgery under general anesthesia and the role of methylene blue to reduce the total requirement of rescue analgesiaTimepoint: 24 hours